COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01275248
Recruitment Status : Terminated (lack of efficacy)
First Posted : January 12, 2011
Last Update Posted : January 18, 2013
Information provided by (Responsible Party):
Transcept Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Terminated
Estimated Primary Completion Date : September 2015
Estimated Study Completion Date : September 2015